Form D/A — Jabez Biosciences, Inc.
0001213900-25-103046 · filed Oct 28, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- —
- Reported amount sold
- $250,510
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Jabez Biosciences, Inc.
- CIK
- 2038185
- Entity
- —
- Jurisdiction
- —
- Year incorporated
- —
- Address
- 2009 Mackenzie Way, Suite 100
Cranberry Twp, Pennsylvania 16066 - Phone
- 888-645-3947
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Tamara Jovonovich · Executive OfficerZionsville, Indiana Find on LinkedIn ↗
-
Brian Cogley · Executive OfficerCranberry Twp, Pennsylvania Find on LinkedIn ↗
-
Robert Lewis · Executive OfficerMadison, Mississippi Find on LinkedIn ↗
-
Bruce Cassidy · DirectorSarasota, Florida Find on LinkedIn ↗
-
Martin Lewis · DirectorPlainview, Texas Find on LinkedIn ↗
-
Michael Lewis · PromoterFort Myers, Florida Find on LinkedIn ↗
-
David Mehalick · PromoterNaples, Florida Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗